Sullivan Adam Taylor

Core Scientific CEO Sullivan sold 369,712 shares at $16.24 on 2025-01-24; stock now -38.0% from 52-week high at $11.31

Sullivan Adam Taylor, Chief Executive Officer, sold 369,712 shares of CORZ at $16.24 on 2025-01-24 for a total value of $6,003,753.17, reducing his holdings from 4,128,505 to 3,758,793 shares (-9.0% of pre-transaction holdings). The sale occurred when the stock was trading well above its current price of $11.31, which now sits -38.0% from the 52-week high and -19.5% over the past 30 days. Core Scientific is unprofitable with net income of $-455,259,000.00 on quarterly revenue of $95,354,000.00, and the company faced a -21.5% annual revenue decline. This represents the CEO's second open-market sale at this ticker within 22 days; his prior buy at CORZ on 2024-03-15 delivered a +221.7% 90-day return, but the current pricing environment has deteriorated significantly since the January 24 sale execution.

CORZ CEO Adam Taylor Sullivan sold 88,380 shares at $14.24 on 2025-01-02; stock now at $15.38, down 15.6% from 52-week high.

Sullivan Adam Taylor, Chief Executive Officer of Core Scientific, sold 88,380 shares for a total value of $1,258,796.34 at $14.24 per share, reducing his holdings by 2.1%. The transaction occurred as the stock trades 15.6% below its 52-week high of $18.23 and has declined 12.0% over the prior 30 days. Core Scientific reported a net loss of $455,259,000.00 in its most recent period against revenue of $95,354,000.00, and the company experienced annual revenue decline of 21.5%, signaling material operational stress. While Sullivan's cross-ticker track record shows strong long-term timing (100% 90-day win rate), his prior trade at CORZ in March 2024 returned +221.7% over 90 days, creating a baseline of successful positioning at this specific security. The current sale against a backdrop of negative earnings, shrinking revenue, and a stock retreating from recent highs warrants monitoring of company fundamentals and further insider activity.